Reporting Coefficient of Variation for Logit, Box-Cox and Other Non-log-normal Parameters.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 133, doi. 10.1007/s40262-023-01343-2
- By:
- Publication type:
- Article
Works matching IS 03125963 AND DT 2024 AND VI 63 AND IP 2
Results: 10
1
2
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 137, doi. 10.1007/s40262-023-01341-4
- By:
- Publication type:
- Article
3
Use of Pharmacokinetic and Pharmacodynamic Data to Develop the CDK4/6 Inhibitor Ribociclib for Patients with Advanced Breast Cancer.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 155, doi. 10.1007/s40262-023-01338-z
- By:
- Publication type:
- Article
4
Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 255, doi. 10.1007/s40262-023-01337-0
- By:
- Publication type:
- Article
5
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 197, doi. 10.1007/s40262-023-01336-1
- By:
- Publication type:
- Article
6
Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 211, doi. 10.1007/s40262-023-01334-3
- By:
- Publication type:
- Article
7
Pharmacokinetics, Pharmacodynamics, and Safety of Single Dose HSK7653 Tablets in Chinese Subjects with Normal or Impaired Renal Function.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 227, doi. 10.1007/s40262-023-01333-4
- By:
- Publication type:
- Article
8
Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 183, doi. 10.1007/s40262-023-01329-0
- By:
- Publication type:
- Article
9
Pharmacokinetics, Disposition, and Biotransformation of [<sup>14</sup>C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 241, doi. 10.1007/s40262-023-01328-1
- By:
- Publication type:
- Article
10
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 171, doi. 10.1007/s40262-023-01309-4
- By:
- Publication type:
- Article